PEPTIDETACTICS

RESEARCH

Peptide purity explained

A purity percentage on its own carries less information than it appears to. Purity is the output of a specific method run under specific conditions, and without those conditions the number cannot be compared meaningfully against anything else.

What a purity figure measures

For synthetic peptides, a purity figure almost always means chromatographic purity determined by reversed-phase HPLC. The sample is separated on a column, a detector records absorbance as material elutes, and the area of the main peak is expressed as a percentage of the total integrated peak area.

That is an area-percent measurement, not a mass measurement. It describes how much of the detected signal is attributable to the main component relative to everything else that was detected.

Why the detection wavelength changes the answer

Peptide HPLC is usually monitored in the ultraviolet region, commonly at 214–220 nm, where the peptide bond itself absorbs, or at 280 nm, where tryptophan and tyrosine absorb.

These two choices can give materially different numbers for the same sample. Detection at 214 nm responds to essentially every peptide species present, because every peptide has amide bonds. Detection at 280 nm responds only to species containing aromatic residues, so an impurity lacking tryptophan or tyrosine can be substantially under-represented or invisible.

This is why a purity claim without a stated wavelength is incomplete. A figure at 280 nm is not directly comparable to a figure at 214 nm.

What a purity figure does not tell you

A purity percentage says nothing about identity. A chromatogram showing a single sharp peak demonstrates that one species dominates the detected signal; it does not demonstrate that the species is the peptide you intended to buy. Identity requires mass spectrometry, and ideally sequence-level confirmation.

Nor does purity describe how much peptide is in the vial. Counter-ions, residual water and residual solvent all contribute mass without appearing as chromatographic impurities. Net peptide content is the separate figure that addresses this.

Finally, a purity figure describes one batch analysed on one occasion. It is not a property of the compound and does not transfer to other batches.

  • Purity does not confirm identity — that requires mass spectrometry.
  • Purity does not equal peptide content by mass — that requires amino acid analysis or an equivalent method.
  • Purity does not describe stability over time — that requires stability data.
  • Purity is batch-specific and does not carry across to other batches.

Common impurities in synthetic peptides

The impurity profile of a synthetic peptide is largely a consequence of how it was made. Deletion sequences, missing one or more residues because a coupling step did not go to completion, are the classic example and are usually the closest-eluting impurities.

Truncated sequences arise when chain assembly terminates early. Oxidation products are common in peptides containing methionine, cysteine or tryptophan; methionine oxidation adds approximately 16 Da and typically shifts retention time earlier on a reversed-phase column.

Deamidation of asparagine and glutamine residues introduces a species approximately 1 Da heavier, which is a small enough difference that it can be missed by low-resolution mass spectrometry while still being separable by chromatography.

Because these impurities are structurally close to the target, they are the hardest to remove — which is exactly why the last few percentage points of purity are disproportionately expensive to achieve.

Reading a purity claim critically

A purity claim is interpretable when it is accompanied by the information needed to reproduce or contextualise it. At minimum that means the method, the detection wavelength, the batch it refers to and the date of analysis.

A claim of "99% purity" attached to a product listing rather than to a specific batch, with no method stated, is a marketing statement rather than an analytical one. It may well be accurate, but nothing in it can be checked.

  • Which method was used, and under what chromatographic conditions?
  • At what wavelength was detection performed?
  • Which batch or lot does the figure describe?
  • When was the analysis performed?
  • Is net peptide content reported separately from chromatographic purity?

Frequently asked questions

Does 99% purity mean the vial is 99% peptide?
No. Chromatographic purity describes the proportion of detected peak area attributable to the main component. The solid in the vial also contains counter-ions and residual water, which do not appear as chromatographic impurities. Net peptide content is the separate figure that describes how much of the solid is peptide.
Why does the detection wavelength matter for a purity figure?
Detection at 214 nm responds to the peptide bond and therefore to essentially all peptide species present. Detection at 280 nm responds only to aromatic residues, so impurities lacking tryptophan or tyrosine may be under-represented. The same sample can give different figures at the two wavelengths.
Does a purity figure confirm that the material is the right peptide?
No. Purity describes composition, not identity. Confirming identity requires mass spectrometry to check that the observed mass matches the expected mass for the intended sequence.

Sources and further reference

Compounds this applies to

The considerations above are not abstract. Each of these compounds is listed in the Peptide Tactics catalog for research use in India, with its reference data, analytical notes and documentation status set out in full.

BPC-157

BPC-157 is a synthetic pentadecapeptide — a chain of fifteen amino acids — corresponding to a partial sequence of the gastric peptide referred to in the literature as body protection compound. It is listed here as a research catalog item with the compound reference data recorded in public chemical databases.

View listing and pricing

MOTS-c

MOTS-c is a 16-residue mitochondrial-derived peptide. It is unusual among the peptides in this catalog because it is encoded within the mitochondrial genome rather than the nuclear genome, in an alternative open reading frame inside the 12S ribosomal RNA gene.

View listing and pricing

CJC-1295 + Ipamorelin

This catalog entry contains two chemically distinct peptides supplied in a single vial: CJC-1295 and ipamorelin, at 5 mg each. Because it is a two-component material, characterising it is a different exercise from characterising a single peptide.

View listing and pricing

See the full research peptide catalog, the India sourcing guide or how to request documentation.

Continue reading